Improving follow-up care for cervical cancer in urban women
Reducing Urban Cervical Cancer Disparities Using a Tailored MHealth Intervention to Enhance Colposcopy Attendance
This study is testing a new text and phone coaching program to help urban women with cervical cancer get the follow-up care they need after abnormal test results.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 546 (estimated) |
| Ages | 18 Years to 90 Years |
| Sex | Female |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Locations | 3 sites (New Brunswick, New Jersey and 2 other locations) |
| Trial ID | NCT06416150 on ClinicalTrials.gov |
What this trial studies
This study aims to reduce cervical cancer disparities by implementing the Health Enhancement Resource System (HERS), which provides text message-based counseling and telephone health coaching to women who miss follow-up appointments after abnormal cervical test results. The intervention is designed to increase patient follow-up rates and is based on a previously successful tailored communication approach. The study will be conducted at multiple urban clinic sites in Pennsylvania and New Jersey, utilizing a randomized trial design to assess the effectiveness of HERS in improving attendance at follow-up appointments.
Who should consider this trial
Good fit: Ideal candidates for this study are women aged 18 to 90 who have been referred for colposcopic evaluation and can communicate in English.
Not a fit: Patients who are currently pregnant, have a history of invasive cervical carcinoma, or require follow-up that does not involve a colposcopy may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve follow-up rates for cervical cancer screenings, ultimately reducing mortality rates in underserved urban populations.
How similar studies have performed: Previous studies have shown success with similar tailored communication interventions, indicating potential for this adapted approach to also be effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 to 90 years of age (screening is still recommended for some women over 65-depending on screening and medical history and proceeds until age 90 in the study's clinic recruitment sites), * referral for colposcopic evaluation at the clinic sites, * able to communicate with ease in English, * have a cell phone with texting ability, and * competent to give consent. Exclusion Criteria: * are pregnant at the time of recruitment, * display current evidence or have a history of positive invasive carcinoma of the cervix, or * require follow-up but not a colposcopy.
Where this trial is running
New Brunswick, New Jersey and 2 other locations
- Rutgers, The State University of New Jersey — New Brunswick, New Jersey, United States (Recruiting)
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States (Recruiting)
- Fox Chase Cancer Center — Philadelphia, Pennsylvania, United States (Recruiting)
Study contacts
- Principal investigator: Suzanne M Miller, PhD — Fox Chase Cancer Center
- Study coordinator: Suzanne M Miller, PhD
- Email: suzanne.miller@fccc.edu
- Phone: 215-728-4069
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.